Introduction/Background Anti-VEGF Dosing Regiments: Review of the Pertinent Studies Comparing the Anti-VEGF Dosing Strategies Conclusions References While ...

Kalaris is a clinical-stage biopharmaceutical company founded by Samsara BioCapital and focused on development of TH103, a ...

The SAILOR study, the largest trial in exudative AMD to date (n = 4307), was a Phase IIIb multicenter, 1-year study evaluating a variable-dosing regimen of 3-monthly intravitreal ranibizumab (0.3 ...

Allovir Inc., which has struggled since late last December, will merge with privately held Kalaris Therapeutics Inc. to develop therapies for treating neovascular and exudative retinal diseases.

Wolynski, ODWorldwide, age-related macular degeneration (AMD) is the leading cause of severe vision loss in people aged 50 or older. Neovascular AMD is an advanced form of the condition, also known as ...

AlloVir has been reeling ever since a trio of phase 3 trial failures last year led the company to shed almost all of its staff. | AlloVir has been reeling after a trio of phase 3 trial failures last ...

The unique feline dermatological cases veterinary professionals can see at the clinic, plus how to approach them ...

This meat is also more likely to be "pale, soft, and exudative", aka slimy, another study found. Researchers report that differences in muscle structure are more likely to cause changes in acidity ...

CBNS, such as turmeric, are natural anti-inflammatory and antioxidant agents that may confer benefits against AMD.

Curcuma-based nutritional supplements (CBNS) have been scientifically established to possess antioxidant and ...

On the other hand, pulmonary hemorrhage is described as a feature of the early exudative phase of prolonged joint artificial ventilation and oxygen therapy in adult patients. 13 Our own experience ...